← Eichor
Study identifier: NCT05326750 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Non-invasive Neurostimulation as a Tool for Diagnostics and Management for Neurodegenerative Diseases

Condition: Alzheimer Disease · Frontotemporal Dementia · Dementia With Lewy Bodies  ·  Sponsor: Kuopio University Hospital

PhaseNA
Planned participants200
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

Double blinded, sham-controlled, randomized trial on repeated transcranial alternating current brain stimulation (tACS) in neurodegenerative diseases. The investigators will evaluate whether a 4-times daily repeated stimulation with gamma tACS on the posterior parietal cortex can improve symptoms in patients with neurodegenerative diseases, including dementia with Lewy Bodies, Alzheimer's disease, idiopathic normal pressure hydrocephalus and Frontotemporal dementia.

This description comes directly from the study's public registry record.

Talk to the study team

Eino Solje, MD, PhD  ·  +358 17 713 311  ·  eino.solje@uef.fi

Always discuss trial participation with your own doctor first.

Locations (1)

Kuopio University HospitalKuopio, FinlandRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05326750